Please assess the completion status of the following clinical trial:

Trial Title: Proton Radiation Therapy With Cisplatin and Etoposide Followed by Surgery in Stage III Non-Small Cell Lung Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Histologically confirmed non-small cell lung cancer with a clinical stage of IIIA~* Candidate for chemoradiation and surgical resection~* Measurable disease~* Life expectancy \> 6 months~* Normal organ and marrow function~Exclusion Criteria:~* Pregnant or breast-feeding~* Prior therapy for lung cancer with chemotherapy~* Prior chest radiation~* Compromised pulmonary function~* Severe neurovascular disease~* History of high cardiac risk including unstable angina~* History of allergic reactions attributed to compounds of similar chemical or biologic composition to cisplatin or etoposide~* Uncontrolled intercurrent illness including, but not limited to ongoing or active infection, symptomatic congestive hear failure, unstable angina pectoris, clinically significant or serious cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements~* History of a different malignancy unless disease-free for at least 3 years and at low risk for recurrence. Individuals with the following cancers are eligible if diagnosed and treated within the past 3 years: cervical cancer in situ, non muscle-invasive bladder cancer, basal cell or squamous cell carcinoma of the skin~* Subjects with HIV

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Radiation, Chemotherapy and Surgery (Type: EXPERIMENTAL): Proton beam radiation, plus chemotherapy with cisplatin and etoposide, followed by surgery.

Based on this trial design, predict the completion outcome and termination type (if applicable).